nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Comparison of Bevacizumab Quantification Results in Plasma of Non-small Cell Lung Cancer Patients Using Bioanalytical Techniques Between LC-MS/MS, ELISA, and Microfluidic-based Immunoassay
|
Iwamoto, Noriko |
|
2019 |
21 |
6 |
p. 1-8 |
artikel |
2 |
Development of In Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation
|
Mohamed, Mohamed-Eslam F. |
|
2019 |
21 |
6 |
p. 1-9 |
artikel |
3 |
Fit-for-Purpose Quality Control System in Continuous Bioanalysis During Long-Term Pediatric Studies
|
Ali, Mohsin |
|
2019 |
21 |
6 |
p. 1-11 |
artikel |
4 |
Fit-for-Purpose Quality Control System in Continuous Bioanalysis During Long-Term Pediatric Studies
|
Ali, Mohsin |
|
|
21 |
6 |
|
artikel |
5 |
How Transporters Have Changed Basic Pharmacokinetic Understanding
|
Benet, Leslie Z. |
|
2019 |
21 |
6 |
p. 1-6 |
artikel |
6 |
Inhibition of Hepatic CYP2D6 by the Active N-Oxide Metabolite of Sorafenib
|
Murray, Michael |
|
2019 |
21 |
6 |
p. 1-10 |
artikel |
7 |
On the Comparison of Methods in Analyzing Bounded Outcome Score Data
|
Hu, Chuanpu |
|
2019 |
21 |
6 |
p. 1-4 |
artikel |
8 |
Optimization of Cancer Treatment in the Frequency Domain
|
Schulthess, Pascal |
|
2019 |
21 |
6 |
p. 1-9 |
artikel |
9 |
Retrospective Analysis of Bioanalytical Method Validation Approaches in Biosimilar Biological Product Development
|
Obianom, O. N. |
|
2019 |
21 |
6 |
p. 1-8 |
artikel |